COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,026 Articles (22,627 medRxiv, 8,399 bioRxiv)

Most recent first Previous |  Page 2199: Articles 21981-21990  | Next

A vaccine built from potential immunogenic pieces derived from the SARS-CoV-2 spike glycoprotein
Marchan, J. G.
10.1101/2020.09.24.312355 — Posted: 2020-09-24
Functional genomic screens identify human host factors for SARS-CoV-2 and common cold coronaviruses
Wang, R., Simoneau, C. R., Kulsuptrakul, J., Bouhaddou, M., Travisano, K., Hayashi, J. M., Carlson-Stevermer, J., Oki, J., Holden, K., Krogan, N. J., Ott, M., Puschnik, A. S.
10.1101/2020.09.24.312298 — Posted: 2020-09-24
An evolutionary portrait of the progenitor SARS-CoV-2 and its dominant offshoots in COVID-19 pandemic
Kumar, S., Tao, Q., Weaver, S., Sanderford, M. D., Caraballo, M., Sharma, S., Kosakovsky Pond, S. L., Miura, S.
10.1101/2020.09.24.311845 — Posted: 2020-09-24
Resveratrol And Pterostilbene Potently Inhibit SARS-CoV-2 Infection In Vitro
ter Ellen, B. M., Dinesh Kumar, N., Bouma, E. M., Troost, B., van de Pol, D. P. I., van der Ende-Metselaar, H. H., Apperloo, L., van Gosliga, D., van den Berge, M., Nawijn, M. C., van der Voort, P. H. J., Moser, J., Rodenhuis-Zybert, I. A., Smit, J. M.
10.1101/2020.09.24.285940 — Posted: 2020-09-24
Hamster and ferret experimental infection with intranasal low dose of a single strain of SARS-CoV-2
Monchatre-Leroy, E., Lesellier, S., Wasniewski, M., Picard-Meyer, E., Richomme, C., Boue, F., Lacote, S., Murri, S., Pulido, C., Vulin, J., Salguero, F. J., Legouilh, M. A., Servat, A., Marianneau, P.
10.1101/2020.09.24.311977 — Posted: 2020-09-24
S-Trimer, a COVID-19 subunit vaccine candidate, induces protective immunity in nonhuman primates
Liang, J. G., Su, D., Song, T.-Z., Zeng, Y., Huang, W., Wu, J., Xu, R., Luo, P., Yang, X., Zhang, X., Luo, S., Liang, Y., Li, X., Huang, J., Wang, Q., Huang, X., Xu, Q., Luo, M., Huang, A., Luo, D., Zhao, C., Yang, F., Han, J.-B., Zheng, Y.-T., Liang, P.
10.1101/2020.09.24.311027 — Posted: 2020-09-24
Broad-spectrum, patient-adaptable inhaled niclosamide-lysozyme particles are efficacious against coronaviruses in lethal murine infection models
Brunaugh, A. D., Seo, H., Warnken, Z., Ding, L., Seo, S. H., Smyth, H. D. C.
10.1101/2020.09.24.310490 — Posted: 2020-09-24
COVID-19 CG: Tracking SARS-CoV-2 mutations by locations and dates of interest
Chen, A. T., Altschuler, K., Zhan, S. H., Chan, Y. A., Deverman, B. E.
10.1101/2020.09.23.310565 — Posted: 2020-09-24
Role of IgG against N-protein of SARS-CoV2 in COVID19 clinical outcomes
Batra, M., Tian, R., Zhang, C., Clarence, E., Sacher, C. S., Miranda, J. N., Rafa O De La Fuente, J., Mathew, M., Green, D., Patel, S., Virginia Perez Bastidas, M., Haddadi, S., Murthi, M., Santiago Gonzalez, M., Kambali, S., Santos, K. H., Asif, H., Modarresi, F., Faghihi, M., Mirsaeidi, M.
10.1101/2020.09.23.20197251 — Posted: 2020-09-24
Modelling optimal vaccination strategy for SARS-CoV-2.
Moore, S., Hill, E. M., Dyson, L., Tildesley, M., Keeling, M. J.
10.1101/2020.09.22.20194183 — Posted: 2020-09-24 Discussion: Onsite

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).